Expression of Cytotoxic Proteins in Peripheral T-Cell and Natural Killer-Cell (NK) Lymphomas: Association with Extranodal Site, NK or Tγδ Phenotype, Anaplastic Morphology and CD30 Expression

References

• Harris N L, Jaffe E S, Stein H. A revised European-American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Gaulard P, Bourquelot P, Kanavaros P. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of 78 T-cell lymphomas. Am J Pathol 1990; 137: 617–628
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Krenacs L, Kumar S, Kingma D W, Raffeld M. Extranodal peripheral T-cell and NK-cell neoplasms. Am J Clin Pathol 1999; 111: S 46–S 55, (Suppl 1)
   Google Scholar
• Cook C, Krenacs L, Settler-Stevenson M. Hepat-osplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic γδ T-cell origin. Blood 1996; 88: 4265–4274
   PubMed Web of Science ®Google Scholar
• Kanavaros P, Lescs M C, Briere J. Nasal T-cell lymphoma; a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688–2695
   PubMed Web of Science ®Google Scholar
• Kiney M C. The role of morphologic features, phenotype, genotype and anatomic site in defining extranodal T-cell and NK-cell neoplasms. Am J Clin Pathol 1999; 111: S104–S108, (suppl 1)
   PubMed Web of Science ®Google Scholar
• Wong K F, Chan J KC, Matutes E. Hepatosplenic γδ T-cell lymphoma: a distinctive aggressive lymphoma type. Am J Surg Pathol 1995; 19: 718–726
   PubMed Web of Science ®Google Scholar
• Kanavaros P, Briere J, Emile J F, Gaulard P. Epstein-Barr Virus in T and natural killer Non-Hodgkin's lymphomas. Leukemia 1996; S2: S84–S87
   Google Scholar
• Emile J F, Boulland M L, Haioun C. CD5-,CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996; 87: 1466–1473
   PubMed Web of Science ®Google Scholar
• Kanavaros P, Briere J, Lescs M C, Gaulard P. EBV in NHL of the upper respiratory tract: association with sinonasal localization and expression of NK and/or T-cell antigens by tumour cells. J Pathology 1996; 178: 297–302
   PubMed Web of Science ®Google Scholar
• Kaneko T, Fukuda J, Yoshihara T. Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr Virus and expressing CD21 antigen and comparative studies of their phenotype and cytotoxicity with normal NK cells. Br J Haemat 1995; 91: 355–361
   PubMed Web of Science ®Google Scholar
• Ng C S, Lo S TH, Chan J KC. Peripheral T and putative Natural Killer cell lymphomas commonly coexpress CD95 and CD95 ligand. Hum Pathol 1999; 30: 48–53
   PubMed Web of Science ®Google Scholar
• Liu C C, Walsh C M, Young J DE. Perforin: structure and function. Immunology Today 1995; 16: 194–201
   PubMedGoogle Scholar
• Smyth M J, Trapani J A. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995; 16: 202–206
   PubMedGoogle Scholar
• Froelich C. J., Dixit V. M., Yang X. Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. Immunol Today 1998; 19: 30–36
   PubMedGoogle Scholar
• Krenacs L, Wellmann A, Sorbara L. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and Null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997; 89: 980–989
   PubMed Web of Science ®Google Scholar
• Felgar R, Macon W, Kinney M. TIA-1 Expression in Lymphoid Neoplasms. Identification of Subsets with Cytotoxic T Lymphocyte or Natural Killer Cell Differentiation. Am J Pathol 1997; 150: 1893–1900
   PubMed Web of Science ®Google Scholar
• Ng C S, Lo S TH, Chan J KC, Chan W C. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis. Hum Pathol 1997; 28: 1276–1282
   PubMed Web of Science ®Google Scholar
• Daum S, Foss H D, Anagnostopoulos I. Expression of cytotoxic molecules in intestinal T-cell lymphomas. J Pathol 1997; 182: 311–317
   PubMed Web of Science ®Google Scholar
• Kummer J A, Vermeer M H, Dukers D. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol 1997; 109: 636–640
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Yatabe Y, Tsuzuki T. Perforin and granzyme expression in cytotoxic T-cell lymphomas. Mod Pathol 1998; 11: 313–323
   PubMed Web of Science ®Google Scholar
• De Bruin P C, Kummer J A, Van der valk P. Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue (MALT) localization. Blood 1994; 84: 3785–3791
   PubMed Web of Science ®Google Scholar
• Mori N, Yatabe Y, Oda K. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation. Am J Pathol 1996; 149: 699–705
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Chan J KC, Su I J. Report of the Workshop on Nasal and related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis and epidemiology. Am J Surg Pathol 1996; 20: 103–111
   PubMed Web of Science ®Google Scholar
• Foss H D, Anagnostopoulos I, Araujo I. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996; 88: 4005–4011
   PubMed Web of Science ®Google Scholar
• Boulland M L, Kanavaros P, Weschler J, Casiraghi O, Gaulard P. Cytotoxic protein expression in NK-NHL and in αβ and γδ peripheral T-cell lymphomas. J Pathology 1997; 182: 432–437
   Google Scholar
• Arnulf B, Copie-Bergman C, Delfau-Larue M H. Nonhepatosplenic γδ T-cell lymphoma: A subject of cytotoxic lymphomas with mucosal or skin localization. Blood 1998; 91: 1723–1731
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Vlychou M., Stefanaki K. Cytotoxic protein expression in non-Hodgkin's lymphoma and Hodgkin's disease. Anticancer Res 1999; 19: 1209–1216
   PubMed Web of Science ®Google Scholar
• Boulland M L, Weshler J, Bagot M, Kanavaros P, Gaulard P. Primary CD30+ cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic molecules. Histopathology, (in press) in press
   Web of Science ®Google Scholar
• Tetuya-Feldstein J, Jaffe E S, Burd P R. The role of Mig, the monokine induced by interferon-γ and IP- 10, the interferon-y inducible protein 10, in tissue necrosis and vascular damage associated with EBV-positive lymphoproliferation disease. Blood 1997; 90: 4099–4105
   PubMed Web of Science ®Google Scholar
• Salhany K E, Macon W R, Choi J K. Subcutaneous panniculitis-like T-cell lymphoma: Clinicopathologic, immunophenotypic and genotypic analysis of αβ and γδ subtypes. Am J Surg Pathol 1997; 22: 881–893
   Web of Science ®Google Scholar
• Salhany K, Feldman M, Kahn M. Hepatosplenic γδ T-cell lymphoma: Ultrastructural, immunophenotypic and functional evidence for cytotoxic T-lymphocyte differentiation. Hum Pathol 1997; 28: 674–685
   PubMed Web of Science ®Google Scholar
• Kumar S, Krenacs L, Elenitoba-Johnson K. Subcutaneous panniculitis T-cell lymphoma is a tumor of cytotoxic T-lymphocytes. Hum Pathol 1998; 29: 397–403
   PubMed Web of Science ®Google Scholar
• Matutes E, Coelho E, Aguado M-J. Expression of TIA-1 and TIA-2 in T-cell malignancies and T cell lymphocytosis. J Clin Pathol 1996; 49: 154–158
   PubMed Web of Science ®Google Scholar
• Felgar R, Salhany K, Macon W, Pietra G, Kinney M. The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure and clinical features. Hum Pathol 1999; 30: 228–236
   PubMed Web of Science ®Google Scholar
• Ohshima K, Suzumiya J, Sugihara M. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas including αβ, γδ T-cell and natural killer origin. Virchows Arch 1999; 435: 92–100
   PubMed Web of Science ®Google Scholar
• Vermeer M, Geelen F, Kummer A, Meijer C, Willemze R. Expression of cytotoxic proteins by neoplastic T-cells in mucosis fungoides increases with progression from plaque stage to tumor stage disease. Am J Pathol 1999; 154: 1203–1210
   PubMed Web of Science ®Google Scholar
• Berti E, Tomasini D, Vermeer M H, Meijer C L, Alessi E, Willemze R. Primary cutaneous CD8-positive epider-motropic cytotoxic T cell lymphomas. A distinct clinicopathologic entity with an aggressive clinical behaviour. Am J Pathol 1999; 155: 483–492
   PubMed Web of Science ®Google Scholar
• Chott A, Haedicke W, Mosberger I. Most CD56+ intestinal lymphomas are CD8+CD5- T-cell lymphomas of monomorphic to medium size histology. Am J Pathol 1998; 153: 1483–1490
   PubMed Web of Science ®Google Scholar
• DeBruin P C, Connolly C E, Oudejans J J. Enter-opathy-associated T-cell lymphomas have a cytotoxic T-cell phenotype. Histopathology 1997; 31: 313–317
   PubMed Web of Science ®Google Scholar
• Bluestone J A, Khatti R, Sciammas R, Al Sperling. TCR γδ cells. A specialized T-cell subset in the immune system. Annu Rev Cell Dev Biol 1995; 11: 307–353
   PubMed Web of Science ®Google Scholar
• Susskind B, Shomick M D, Iannoti M R. Cytolytic effector mechanisms of human CD4+ cytotoxic T-lymphocytes. Hum Immunol 1996; 45: 64–75
   PubMed Web of Science ®Google Scholar
• Tao Q, Srivastava G, Dickens P, Ho F CS. Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps. Am J Pathol 1996; 149: 1111–1118
   PubMed Web of Science ®Google Scholar
• Oberhuber G, Vogelsang H, Stolte M, Muthenthaler S, Kummer A J, Radaszkiewcz T. Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis. Am J Pathol 1996; 148: 1351–1357
   PubMed Web of Science ®Google Scholar
• Kanegane H, Yachi A, Miyawaki T, Tosato G. EBV-NK cell interactions and lymphoproliferative disorders. Leuk Lymphoma 1998; 29: 491–498
   PubMed Web of Science ®Google Scholar
• Perry M, Whyte A. Immunology of the tonsils. Immunol Today 1998; 19: 414–420
   PubMedGoogle Scholar
• Kanavaros P, De Bruin P C, Briere J, Meijer C JLM, Gaulard P. Epstein-Barr virus (EBV) in extranodal T-cell non-Hodgkin's lymphomas (T-NHL). Identification of nasal T-NHL as a dinstict clinicopathologic entity associated with EBV. Leuk Lymphoma 1995; 18: 27–34
   PubMed Web of Science ®Google Scholar
• Chiang A KS, Chan A CL, Srivastava G. Nasal T/Natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus infected cytotoxic lymphocytes of both NK and T-cell lineage. Int J Cancer 1997; 73: 332–338
   PubMed Web of Science ®Google Scholar
• Chiang A K, Wong K Y, Liang A C, Srivastava G. Comparative analysis of EBV gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy. Int. J. Cancer 1999; 80: 356–364
   Web of Science ®Google Scholar
• Chan J FC, Sin V C, Wong K F. Non-nasal lymphoma expressing the natural killer marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89: 4501–4513
   PubMed Web of Science ®Google Scholar
• Macon W R, Williams M E, Greer J P. Natural-killer like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 1996; 87: 1474–1483
   PubMed Web of Science ®Google Scholar
• Mizuki M, Ueda S, Tagawa S. Natural-killer cell derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bite and reactivated Epstein-Barr virus infection. Am J Hematol 1998; 59: 309–315
   PubMed Web of Science ®Google Scholar
• Ott M, Ott G, Klinker H, Trunk M, Katzehberger T, Muller-Hermenlink H. Abdominal T-cell non-Hodgkin's lymphoma of the gamma-delta type in a patient with selective immunoglobulin A deficiency. Am J Surg Pathol 1998; 22: 500–506
   PubMed Web of Science ®Google Scholar
• Ross C W, Schnitzer B, Sheldon S, Braun D K, Hanson C A. Gamma/delta T-cell posttransplantation lympho-proliferative disorder primarily in the spleen. Am J Clin Pathol 1994; 102: 310–314
   PubMed Web of Science ®Google Scholar
• Hsu S M, Waldron J W, Hsu P L, Hough A J. Cytokines in malignant lymphomas: review and perspective evaluation. Hum Pathol 1993; 24: 1040–1057
   PubMed Web of Science ®Google Scholar
• Warren H S, Kinnear B F, Kastelein R L, Lanier L L. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK. cells. J Immunol 1996; 156: 3254–3259
   PubMed Web of Science ®Google Scholar
• Boulland M L, Meignin V, Leroy-Viard K. Human interleukin-10 expression in T/NK-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas. Am J Pathol 1998; 153: 1229–1237
   PubMed Web of Science ®Google Scholar
• Chen W F, Zlontnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991; 147: 528–534
   PubMed Web of Science ®Google Scholar
• Yagi H, Tokura Y, Furukawa F, Takigawa M. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-y. J Invest Dermatol 1996; 107: 827–832
   PubMed Web of Science ®Google Scholar
• Zambello R, Facco M, Trentin L. Interleukin 15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 1997; 89: 201–211
   PubMed Web of Science ®Google Scholar
• Cheung M MC, Chan J FK, Lau W H. Primary non-Hodgkin's lymphomas of the nose and nasopharynx. Clinical features, tumor immunophenotype and treatment outcome in 113 patients. J Clin Oncol 1998; 16: 70–77
   PubMed Web of Science ®Google Scholar
• Tilly H, Gaulard P, Lepage E. Primary anaplastic large-cell lymphoma in adults: Clinical presentation, immunophenotype and outcome. Blood 1997; 90: 3727–3734
   PubMed Web of Science ®Google Scholar
• The non-Hodgkin's lymphoma classification project. A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. Blood 1997; 11: 3909–3918
   Google Scholar
• Gruss H J, Boiani N, Williams D E. Pleotropic effects of the CD30 ligand on CD30 expressing cells and lymphoma cell lines. Blood 1994; 83: 2045–2056
   PubMed Web of Science ®Google Scholar
• Chan A C, Ho J W, Chiang A K, Srivastava G C. Phenotypic and cytotoxic characteristics of peripheral T-cell and NK-cell lymphomas in relation to Epstein-Barr virus association. Histopathology 1999; 34: 16–24
   PubMed Web of Science ®Google Scholar
• Oudejans J, Kummer J, Jiwa M. Granzyme B expression in Reed-Stemberg cells of Hodgkin's disease. Am J Pathol 1996; 148: 233–240
   PubMed Web of Science ®Google Scholar